These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 18456002)

  • 21. α-Synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson's disease.
    Harischandra DS; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
    Toxicol Sci; 2015 Feb; 143(2):454-68. PubMed ID: 25416158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondrial targeting of the human peptide methionine sulfoxide reductase (MSRA), an enzyme involved in the repair of oxidized proteins.
    Hansel A; Kuschel L; Hehl S; Lemke C; Agricola HJ; Hoshi T; Heinemann SH
    FASEB J; 2002 Jun; 16(8):911-3. PubMed ID: 12039877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of DJ-1 neuroprotection in a cellular model of Parkinson's disease.
    Liu F; Nguyen JL; Hulleman JD; Li L; Rochet JC
    J Neurochem; 2008 Jun; 105(6):2435-53. PubMed ID: 18331584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methionine sulfoxide reductase A protects neuronal cells against brief hypoxia/reoxygenation.
    Yermolaieva O; Xu R; Schinstock C; Brot N; Weissbach H; Heinemann SH; Hoshi T
    Proc Natl Acad Sci U S A; 2004 Feb; 101(5):1159-64. PubMed ID: 14745014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidants induce alternative splicing of alpha-synuclein: Implications for Parkinson's disease.
    Kalivendi SV; Yedlapudi D; Hillard CJ; Kalyanaraman B
    Free Radic Biol Med; 2010 Feb; 48(3):377-83. PubMed ID: 19857570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Valeric Acid Protects Dopaminergic Neurons by Suppressing Oxidative Stress, Neuroinflammation and Modulating Autophagy Pathways.
    Jayaraj RL; Beiram R; Azimullah S; Mf NM; Ojha SK; Adem A; Jalal FY
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methionine oxidation, alpha-synuclein and Parkinson's disease.
    Glaser CB; Yamin G; Uversky VN; Fink AL
    Biochim Biophys Acta; 2005 Jan; 1703(2):157-69. PubMed ID: 15680224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methionine Sulfoxide Reductase A Deficiency Exacerbates Cisplatin-Induced Nephrotoxicity via Increased Mitochondrial Damage and Renal Cell Death.
    Noh MR; Kim KY; Han SJ; Kim JI; Kim HY; Park KM
    Antioxid Redox Signal; 2017 Oct; 27(11):727-741. PubMed ID: 28158949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease.
    Burbulla LF; Song P; Mazzulli JR; Zampese E; Wong YC; Jeon S; Santos DP; Blanz J; Obermaier CD; Strojny C; Savas JN; Kiskinis E; Zhuang X; Krüger R; Surmeier DJ; Krainc D
    Science; 2017 Sep; 357(6357):1255-1261. PubMed ID: 28882997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The yeast peptide-methionine sulfoxide reductase functions as an antioxidant in vivo.
    Moskovitz J; Berlett BS; Poston JM; Stadtman ER
    Proc Natl Acad Sci U S A; 1997 Sep; 94(18):9585-9. PubMed ID: 9275166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methionine sulfoxide reduction in mammals: characterization of methionine-R-sulfoxide reductases.
    Kim HY; Gladyshev VN
    Mol Biol Cell; 2004 Mar; 15(3):1055-64. PubMed ID: 14699060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methionine sulfoxide reductase A (MsrA) mediates the ubiquitination of 14-3-3 protein isotypes in brain.
    Deng Y; Jiang B; Rankin CL; Toyo-Oka K; Richter ML; Maupin-Furlow JA; Moskovitz J
    Free Radic Biol Med; 2018 Dec; 129():600-607. PubMed ID: 30096435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deletion of mouse MsrA results in HBO-induced cataract: MsrA repairs mitochondrial cytochrome c.
    Brennan LA; Lee W; Cowell T; Giblin F; Kantorow M
    Mol Vis; 2009 May; 15():985-99. PubMed ID: 19461988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repair of oxidized proteins. Identification of a new methionine sulfoxide reductase.
    Grimaud R; Ezraty B; Mitchell JK; Lafitte D; Briand C; Derrick PJ; Barras F
    J Biol Chem; 2001 Dec; 276(52):48915-20. PubMed ID: 11677230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteasome mediates dopaminergic neuronal degeneration, and its inhibition causes alpha-synuclein inclusions.
    Sawada H; Kohno R; Kihara T; Izumi Y; Sakka N; Ibi M; Nakanishi M; Nakamizo T; Yamakawa K; Shibasaki H; Yamamoto N; Akaike A; Inden M; Kitamura Y; Taniguchi T; Shimohama S
    J Biol Chem; 2004 Mar; 279(11):10710-9. PubMed ID: 14672949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxidation of methionine 35 reduces toxicity of the amyloid beta-peptide(1-42) in neuroblastoma cells (IMR-32) via enzyme methionine sulfoxide reductase A expression and function.
    Misiti F; Clementi ME; Giardina B
    Neurochem Int; 2010 Mar; 56(4):597-602. PubMed ID: 20060866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 4E-BP1 Protects Neurons from Misfolded Protein Stress and Parkinson's Disease Toxicity by Inducing the Mitochondrial Unfolded Protein Response.
    Dastidar SG; Pham MT; Mitchell MB; Yeom SG; Jordan S; Chang A; Sopher BL; La Spada AR
    J Neurosci; 2020 Nov; 40(45):8734-8745. PubMed ID: 33046555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Catalytic advantages provided by selenocysteine in methionine-S-sulfoxide reductases.
    Kim HY; Fomenko DE; Yoon YE; Gladyshev VN
    Biochemistry; 2006 Nov; 45(46):13697-704. PubMed ID: 17105189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of methionine/selenomethionine oxidation and methionine sulfoxide reductase function using methionine-rich proteins and antibodies against their oxidized forms.
    Le DT; Liang X; Fomenko DE; Raza AS; Chong CK; Carlson BA; Hatfield DL; Gladyshev VN
    Biochemistry; 2008 Jun; 47(25):6685-94. PubMed ID: 18505275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration.
    Oliveras-Salvá M; Van der Perren A; Casadei N; Stroobants S; Nuber S; D'Hooge R; Van den Haute C; Baekelandt V
    Mol Neurodegener; 2013 Nov; 8():44. PubMed ID: 24267638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.